BPC 157 dose

The stated BPC-157 dose is 300–500 micrograms subcutaneously, two to three times per week, for about eight weeks. The dose and schedule are described as typical practice, not as an established human dose; human clinical evidence is limited. 1 2

• Cycling: After the course, the described practice is to cycle off for eight to ten weeks. 3
• Frequency and monitoring: Continuous daily use is discouraged; if using it, the advice is to use the minimum effective dose and monitor health metrics for signs of possible tumor or cancer growth. 4
• Pentadeca arginate: The alternative dose mentioned is 250–500 micrograms injected daily, with a schedule of five days on and two days off. 5 6